Wexford Capital’s GE HealthCare GEHC Stock Holding History

Wexford Capital’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-11,350	Closed	-$931K	–	222
2023 Q1	$931K	Buy	+11,350	New	+$810K	0.19%	70

Other funds holding GEHC

General Electric Evendale, Ohio $308M AUM 40.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return

Wexford Capital's GEHC Position: Q2 2023 in Review

Wexford Capital sold out of GE HealthCare (GEHC) in Q2 2023, closing a stake of 11,350 shares — an estimated $931K sold.

Wexford Capital first reported a position in GEHC in Q1 2023 and held it in 1 quarter. The position peaked at $931K in Q1 2023. 1,133 funds tracked by Wall St. Rank hold GEHC as of Q2 2023.

Wexford Capital reported no remaining GE HealthCare position as of Q2 2023 after selling out during the quarter.
Wexford Capital sold 11,350 GE HealthCare shares in Q2 2023, an estimated $931K.
Wexford Capital first reported a position in GE HealthCare in Q1 2023 and held it in 1 quarter.
Wexford Capital's GE HealthCare position peaked at $931K in Q1 2023.
1,133 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2023.

Based on Wexford Capital's 13F filing for Q2 2023, filed 14 Aug 2023.